Related Experiment Videos
The role of alpha interferon in the biomodulation of disease: preface
1Albert Einstein Cancer Center, Bronx, New York, USA.
Medical Oncology (Northwood, London, England)
|March 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Expression of retinoic acid receptor-beta 2 mRNA in normal cervical epithelium and cervical squamous cell carcinoma.
International journal of oncology·2011
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2003
Advances in the treatment of metastatic colorectal cancer.
Clinical colorectal cancer·2002
Perspectives for cancer therapies with cdk2 inhibitors.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2002
Stage 4 squamous cell carcinoma of the tongue in a child: complete response to chemoradiotherapy.
Journal of pediatric hematology/oncology·2002
Curcumin in ovarian cancer: mechanistic insights and translational potential.
Medical oncology (Northwood, London, England)·2026
Silencing the genome: role of HUSH complex in retrotransposon regulation and cancer development.
Medical oncology (Northwood, London, England)·2026
Nutritional inflammatory hematological risk index predicts clinical outcomes in patients with advanced NSCLC receiving immunotherapy.
Medical oncology (Northwood, London, England)·2026
Nano-Diosmin mitigates EAC-induced renal injury through Nrf2-mediated antioxidant activation and NF-κB-dependent apoptotic suppression.
Medical oncology (Northwood, London, England)·2026
A20 promotes OPN ubiquitination and degradation to inhibit cell growth and invasion in human hepatocellular carcinoma.
Medical oncology (Northwood, London, England)·2026
GLIS3 promotes the malignant biological behavior of gastric cancer cells by transcriptionally regulating PNPO to influence autophagy.
Medical oncology (Northwood, London, England)·2026